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Extraocular muscleto be required at various levels of eye patterning via Retinoic Acid Receptors
(RAR); however the molecular and cellular mechanisms triggered by these nuclear receptors are still obscure.
The genetic studies performed here enable us to present a new model to study RA action during eye
development. By inactivating the three RARs, speciﬁcally in the periocular mesenchyme, we discriminate the
individual contribution of each RAR during eye development and describe a new function for RARs during
the formation of the optic nerve. We demonstrate that RARα is the only receptor that mediates RA signalling
in the neurectoderm during ocular development. Surprisingly, and despite a sophisticated pattern of RA-
activity in the developing retina, we observed that RA signalling is not autonomously required in this tissue
for eye formation. We show that the action of RA during eye morphogenesis is occurring speciﬁcally in neural
crest-derived periocular mesenchyme and is mediated by all three RARs. Furthermore, we point out that
Pitx2, which encodes a homeodomain transcription factor, is a key RA-responsive gene in neural crest cells
during eye development. Interestingly, we observed that RA is required in the neural crest cells for normal
position of the extraocular muscle.
© 2008 Elsevier Inc. All rights reserved.Introduction
During vertebrate development, the eye is constructed from neural
and surface ectoderm as well as from the periocular mesenchyme
(POM). This latter tissue derives from neural crest cells (NCCs) and
mesoderm. The primary function of ocular mesenchyme is to provide
multiple mature cell lineages that are necessary for the development
of normal anterior segments (including the corneal endothelium,
anterior chamber and iris stroma). A second essential function is that
cells originating from the surface epithelium need to interact with
POM cells for proper eyelid development (Le Lievre and Le Douarin,
1975). Finally, the POM provides essential signals for the speciﬁcation
of retinal pigmented epithelium (RPE) and the differentiation of the
optic stalk, both structures arising from neural ectoderm (Evans and
Gage, 2005; Fuhrmann et al., 2000). Failure of proper interactions
between these ectodermal tissues and the POM results in develop-
mental disorders such as Peters’ anomaly, Axenfeld-Riegers’s syn-
drome or aniridia (Lines et al., 2002).l crest cell; POM, periocular
e dehydrogenase; RAR, retinoic
cis–RA receptor, VAD, vitamin
pé).
l rights reserved.Vitamin A (retinol) is known to be critical for vertebrate eye dev-
elopment as demonstrated by severe ocular defects occurring after
gestational vitamin A deﬁciency, such as microphthalmia and colo-
boma of the retina (Dickman et al., 1997). Administration of Retinoic
acid (RA), the active metabolite of vitamin A, can rescue these eye
defects indicating that RA mediates the developmental actions of
vitamin A (Dickman et al.,1997). RA signalling is transduced by speciﬁc
nuclear retinoic acid receptor heterodimers (RXRα/RARα, RXRα/RARβ
and RXRα/RARγ) that act as transcription factors and regulate speciﬁc
target genes during development. During the last decade, extensive
work has been done to decipher the molecular mechanisms triggered
by RA during vertebrate development and notably in eye patterning
(for a review see Mark et al., 2006). In particular, numerous gene
knockout studies have demonstrated that the three RARs (RARα, RARβ
and RARγ) play important and overlapping roles during eye develop-
ment (Ghyselinck et al., 1997; Lohnes et al., 1994). Embryos carrying a
nullmutation of only one RAR display relativelyminor defects, but loss
of function of two RARs results in several ocular abnormalities,
includingmalformation of the eyelids, shortening of the ventral retina,
coloboma and severe malformation of the anterior segment (absence
of the iris stroma, the corneal stroma and the anterior chamber).
Although obvious redundancy between RARs has been documen-
ted, accurate comparison of phenotype between various combinations
of RAR knockout mice has led to the attribution of speciﬁc function to
a given RAR. For instance, while all three RARs are expressed in
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2001), several lines of evidence suggest that RXRα/RARβ and RXRα/
RARγ are the main heterodimers which are instrumental in ocular
morphogenesis (Kastner et al., 1997; Zhou et al., 2001). Therefore, a
clearly established function for RARα in the eye has not yet emerged.
During development, RA is generated by speciﬁc cells in a unique
spatio-temporal pattern (Rossant et al., 1991). The ﬁrst enzymatic step,
the oxidation of retinol to retinal, is performed by the retinol dehydro-
genase RDH10 (Sandell et al., 2007). Then, three RA–synthesizing
enzymes (ALDH1A1, ALDH1A2 and ALDH1A3) are involved in RA
synthesis during mouse eye development (Matt et al., 2005; Mic et al.,
2004). They have distinct tissue-speciﬁc expression patterns from the
optic vesicle to the optic cup as ocular formation proceeds. The
distribution of ALDH1As and the RA-degrading enzymes within the
retina produces a dorsal and a ventral domain of RA separated by a
central zone lacking RA activity (Wagner et al., 2000). This particular
dorso-ventral pattern of RA activity observed during neural retina
formation was initially thought to be crucial for eye development
(Wagner et al., 2000). However, so far no conclusive data has been
reported to support such a role for RA (Halilagic et al., 2007;Matt et al.,
2005; Molotkov et al., 2006). ALDH1A2 which is the ﬁrst enzyme
expressed during ocular development is required between E8.5 and
E9.5 for the initial formation of the optic pit (Mic et al., 2004;
Niederreither et al., 1999; Ribes et al., 2006). Aldh1a3-null embryos
display only discrete ocular malformations despite a loss of ventral RA
signalling (Dupé et al., 2003) and partial loss of dorsal RA signalling in
Aldh1a1-null mice does not induce any abnormal eye development
(Fan et al., 2003; Matt et al., 2005). Finally, despite a non-overlapping
expression pattern of their genes, a functional compensation between
ALDH1A1, ALDH1A2 and ALDH1A3 has been demonstrated (Halilagic
et al., 2007; Matt et al., 2005; Molotkov et al., 2006). To date, it has
been established that during eye morphogenesis, RA is provided by
the ALDH1A1 and ALDH1A3 enzymes expressed in the epithelial
compartments of the eye (i.e., the retina, retinal pigment epithelium
and corneal ectoderm) (Matt et al., 2005; Molotkov et al., 2006). This
RA signal diffuses in the mesenchymal compartment (i.e., the POM) to
activate RXRα/RARβ and RXRα/RARγ heterodimers. Thus, RA acts in a
paracrine process to pattern the anterior segment. It has also been
shown that RXRα/RARβ and RXRα/RARγ heterodimers control the
extent of cell–death involved in POM remodelling and the expression
of Foxc1 and Pitx2 genes (Matt et al., 2005), which are crucial genes for
the development of the anterior eye segment in mice and humans
(Cvekl and Tamm, 2004). Beside this relatively good knowledge of RA
action during anterior segment development, its function during optic
cup formation is still largely obscure.
The data obtained with various RA-deﬁcient mouse models de-
monstrate unambiguously that RA is required for several morpho-
genetic processes during eye organogenesis. By using conditional
mutations to inactivate all three RARs in the NCCs, we have generated
a new mouse model where RA activity is entirely absent in the NCC-
deriving POM. Not only does our work allow us to interpret the
disparity of eye phenotypes previously observed in various models of
RA deﬁciency, but deﬁnitely demonstrates that RA signalling plays key
roles in eye development exclusively through the POM.
Methods
Mice
Mice, with a mixed C57BL/6–129/Sv (50%:50%) genetic background, were housed in
an animal facility licensed by the FrenchMinistry of Agriculture (agreementN°B67–218–
5) and all animal experiments were supervised by NBG who is qualiﬁed to experiment
with mice, in compliance with the European legislation on care and use of laboratory
animals (agreement N°67–205). Heterozygousmice weremated overnight, and animals
with avaginal plug at noon of the next daywere considered as embryonic day (E) 0.5. The
generation of loxP-ﬂanked (ﬂoxed) Rara (Rara+/L2), Rarb (Rarb+/L2), Rarg (Rarg+/L2) and
Rara-null mice have been previously described (Chapellier et al., 2002a; Chapellier et al.,
2002b; Chapellier et al., 2002c; Lufkin et al., 1993). Wnt1-Cre mouse which carrying atransgene containing a Cre cassette under the control of the Wnt1 promoter was
obtained from A. McMahon (Danielian et al., 1998). The R26R transgenic mice have been
previously described (Soriano, 1999). The Wnt1-Cre and Rara+/L2, Rarb+/L2, Rarg+/L2
parental lines were intercrossed to generate mutant foetuses lacking RARα, RARβ
and RARγ in NCCs (hereafter designated Rara/b/gNCC−/− mice). The resulting embryos
were genotyped for Cre, Rara, Rarb and Rarg using PCR-based methods. The embryos
of a littermate who does not carry the Wnt1-Cre transgene were used as controls.
Rara/b/gNCC−/− mice were obtained at a mendelian ratio, but newborns died at birth
from respiratory distress.
Histology, staining and in situ RNA analysis
For histology experiments, samples were ﬁxed in Bouin’s ﬂuid for 5 days, embedded
in parafﬁn, serially sectioned and stained with Groat’s hematoxylin and Mallory’s
trichrome. For β–galactosidase activity detection, staining was performed as described
(Rossant et al., 1991). In situ RNA hybridizationwas carried out as described (Dupé et al.,
2003). Brieﬂy, the digoxigenin–labeled antisense riboprobes were synthesized using
cDNA as templates (references upon request). In situ hybridizations were performed on
serial histological sections along the entire anteroposterior axis of the head. Terminal
transferase–mediated dUTP-Nick-End-Labeling (TUNEL) was performed using the
Apoptag® kit (Chemicon International).
Results
RARα is the only mediator of RA signalling in the retina
During early eye development, immunolocalization experiments
suggest that Rara, Rarb and Rarg genes are all expressed in the cells
surrounding the developing optic cup (or POM for Peri Ocular
Mesenchyme) whereas RARα would be the only receptor located in
the developing retina and the retinal pigmented epithelium (RPE)
(Mori et al., 2001).
In order to verify this observation, we examined the RA signalling
activity in absence of RARα by crossing a mouse carrying a RAR-lacZ
RA-reporter (Rossant et al., 1991) gene with the Rara-null mutant. The
resulting mouse allowed us to follow the RA signalling activity
spatiotemporally. We have tested RARE-lacZ activity at E10.5, when RA
activity is strong in the retina, RPE and corneal ectoderm and present
as a weaker signal in the POM (Figs. 1A, C). Compared to this char-
acteristic lacZ expression, Rara-null mutant mice carrying the RARE-
lacZ RA-reporter transgene exhibited an alteration of the reporter
activity. On external view, RA signalling activity in the developing
Rara-null eye was slightly reduced in ocular area whereas a signiﬁcant
decrease was observed at the level of the forebrain (Figs. 1A and B). To
further explore lacZ activity in the developing eye, these embryos
were sectioned. We discovered that RA activity was completely lost
speciﬁcally at the level of the neural retina, the RPE and lens whereas
RA activity was normal at the level of the surface ectoderm and the
POM. Identical lacZ activity was observed at E11.5 and E13.5 (data not
shown). These observations strongly support that Rara was the only
RAR implicated in the transduction of RA activity in the neurectoderm
of the developing eye.
Retinal morphology in Rara-null mouse is normal
The previous experiment revealed that Rarawas the only receptor
capable of transducing RA signalling in the retina. Consequently, Rara-
null mutant gives a unique model to study the role of an autonomous-
RA signal during retina development. We thus undertook an histo-
logical analysis of the retina in newborn and adult Rara-null mutants.
As shown in Fig. 1E, newborn mouse retina have a deﬁned ganglion
cell layer and the development of other layers is still under way. There
were no signiﬁcant morphological differences in the retina of control
and Rara-null newborn mice, either in terms of retinal thickness or
with respect to the presence of a ganglion cell layer (Figs. 1E, F). In
addition, no morphological differences were observed in the adult
retina, as Rara-null retina developed normally, displaying the ex-
pected lamination (ganglion cell layer, inner plexiform layer, inner
nuclear layer, outer plexiform layer, outer nuclear layer and photo-
receptors segments) with the same degree of thickness as that of
Fig. 1. Effects of Rara inactivation on the RA-dependent activity of a RARE-lacZ reporter
transgene. Distribution of β−galactosidase activity driven by the RARE-lacZ transgene in
WT (A, C) and Rara-null mutants (B, D) at E10.5 (A–D). RARE-lacZ activity is abolished in
Rara-null in the retina, RPE and lens but not in the surface ectoderm and mesenchymal
cells. Panels C and D are sections from panels A and B respectively. Note the reduced RA
activity at the level of the forebrain. Aspects of retinal histogenesis in WT and Rara-null
mutant at birth (E, F) and adulthood (G, H). c, presumptive corneal ectoderm; ch,
choroids; e, eye; f, forebrain; gcl, ganglion cell layer; inl, inner nuclear layer; ipl, inner
plexiform layer; le, lens; mx, maxillary part of ﬁrst branchial arch; n, optic nerve; onl,
outer nuclear cell layer; opl, outer plexiform layer; pom, periocular mesenchyme; ps,
photoreceptor segments; r, neural retina; rpe, retinal pigmented epithelium.
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Vax2, that are respectively dorsal and ventral neural retina markers
(McLaughlin et al., 2003), was tested and no difference was found
between E10.5 Rara-null mutant and control (data not shown). There-
fore, loss of Rara does not prevent normal lamination of the retina and
survival. These data suggest that the absence of RA signalling in the
retina does not give rise to an obvious defect in eye organization.Consequently, RA is not needed autonomously in the neural retina
and RPE during overall eyemorphogenesis. However, to date, no direct
functional study and quantitative analysis have been performed on
Rara-null adult mice. Therefore RARα could be implicated in more
subtle developmental processes or in physiological aspects of the
vision that we do not have analysed in this work.
Rara/b/gNCC−/− triple mutants exhibit more severe ocular defects than
Rarb/gNCC−/− double mutants
In a previous work, by inactivating Rarg and Rarb speciﬁcally in the
NCCs of the POM, we demonstrated a functional redundancy between
RARβ and RARγ during the formation of the anterior segment, the
eyelids and the ventral retina (Matt et al., 2005). Considering the
severity of the eye phenotype observed in these mutant mice, we
hypothesized at this point that the function of RA in POM was
mediated by RARβ and RARγ. Nevertheless, in order to determine
whether RARα may also function in the POM during ocular dev-
elopment, we removed all three RARs from the NCCs (mutant so called
Rara/b/gNCC−/−). Mice with the alleles of the genes encoding RARα,
RARβ and RARγ ﬂoxed (Rara/b/g L2/L2 mice) were crossed with the
wnt1-Cre transgenic mouse line (Chapellier et al., 2002a; Chapellier
et al., 2002b; Chapellier et al., 2002c; Danielian et al., 1998; Matt et al.,
2005). In parallel, all combinations of double mutants for RAR in
the NCCs were similarly obtained (i.e. Rara/bNCC−/−, Rarb/gNCC−/− and
Rara/gNCC−/−).
Unpredictably, we observed that Rara/b/gNCC−/− mutant displayed a
much more severe eye phenotype compared to Rarb/gNCC−/− (Matt et
al., 2005). Indeed, in contrast to Rarb/gNCC−/−, Rara/b/gNCC−/− mutant
eyes were not visible externally at E18.5 (Figs. 2A–D). However,
examination of histological sections revealed that the two eyes were
present in Rara/b/gNCC−/− mutants but buried within the skull, near the
midline, directly beneath the hypothalamus and at the level of the
optic chiasma (Fig. 2K). The presence of globes that were not
externally visible indicated that Rara/b/gNCC−/− mutants were clinically
anophthalmic. Interestingly, histological examination revealed that
the Rara/b/gNCC−/− mutant eyes were attached to the ventral hypotha-
lamus rather than connected through an extended optic nerve.
Therefore, the Rara/b/gNCC−/− mutant eye was characterized by the
presence of the lens and retina deep within the head mesenchyme
with no evidence of optic nerve differentiation (Figs. 2H–K).
Notably, Rara/b/gNCC−/− embryos had normal lens vesicles at E14.5
suggesting that lens induction and invagination had proceeded
normally in all mutants. However, their lens was rotated ventrally
and distant from the surface. At E18.5, the lens was generally hypo-
plasic, probably due to its deep location during organogenesis and the
presence of a persistent retrolenticular membrane that completely
ﬁlled the space between the retina and the lens (Figs. 2H–K). In E14.5
Rara/b/gNCC−/− embryos, the dorsal retinawaswell developed, and both
neural and pigment epithelium layers were present. At the opposite,
the ventral retina was absent or poorly developed, resulting in a
complete coloboma (Figs. 2H, I). Moreover, Rara/b/gNCC−/− mutant eyes
display eversion of the remaining ventral retina that arises from the
transformation of RPE into neural epithelium. As a consequence,
ventral RPEwas never observed in the ventral side (Fig. 2K). The dorsal
retina and the remnant ventral retina of the Rara/b/gNCC−/− mutant
appeared to be normally multilayered and, despite the absence of
optic nerve, the extend axons entered the ventral hypothalamus and
formed the optic chiasma (Figs. 2H–K). Both the optic nerve and
ventral retina arise from neural ectoderm, indicating that one essen-
tial function of RA in the periocular NCCs is to inﬂuence the dev-
elopment of the neural ectoderm.
Multiple structures partially or totally arising from neural crest are
also absent in Rara/b/gNCC−/− eyes. Similarly to Rarb/gNCC−/− mutants
(Matt et al., 2005) (Fig. 2F and Table 1), the corneal endothelium and
stroma, anterior chamber and eyelids which receive contributions
Fig. 2. Partial or complete absence of RA signalling in the POM results in severe ocular defects. (A–D) External view of E18.5 foetus eye areas. (E–K) Frontal histological sections
through heads of E14.5 (E–I) and E18.5 (J, K) foetuses. In order to illustrate the shortening of the optic nerve, the orientation of the eye in panel G is more transversal, this section does
not allow illustration of the shortening of the ventral retina. Asterisks (F–I, K) indicate undifferentiatedmesenchyme replacing the eyelids and cornea. Arrowhead (A–C) indicates the
eye. c, cornea; d, dorsal retina; e, ear; el, eyelid; er, eversion of the retina; le, lens; m, extraocular muscle; n, optic nerve; oc, optic chiasma; p, persistent retro lenticular membrane;
rpe, retinal pigment epithelium; v, ventral retina.
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eyes and were replaced by a thick layer of loosely organized mesen-
chyme (Figs. 2H, I). The sclera surrounding the eye deriving from the
neural crest was completely absent (Fig. 2K). Interestingly, Rara/gNCC−/−
mutants (Fig. 2G and Table 1) and Rara/g-double null mutants both
display a similar phenotype: the eye was buried, the optic nerve wasTable 1
Eye abnormalities present in Rara/bNCC−/−, Rarb/gNCC−/−, Rara/gNCC−/− and Rara/b/gNCC−/−
Eye defects Rara/bNCC−/− Rarb/gNCC−/− Rara/gNCC−/− Rara/b/gNCC−/−
E14.5 n=4 n=4 n=3 n=6
E18.5 n=2 n=2 n=3 n=4
Shorter ventral retina 0% 100% 100% 100%
Complete agenesis of the
ventral retina
0% 0% 0% 80%
Lens rotation 0% 100% 100% 100%
Persistent retrolenticular
membrane
100% 100% 100% 100%
Absence of the optic nerve 0% 0% 0% 100%
Corneal lenticular stalk 0% 100% 100% 100%
Anterior segment defects 0% 100% 100% (partial) 100%
Eversion of the retina 0% 0% 100% 100%
Coloboma 0% 0% 100% 100%
Agenesis of the eyelid 0% 100% 100% (partial) 100%
Note that the single abnormality observed in Rara/bNCC−/− mutant, consisting of a
persistent retrolenticular membrane, was also observed in RarbNCC−/− single mutant.present but shorter and the ventral retina was underdeveloped
(Lohnes et al., 1994). Importantly, in Rara/gNCC−/− mutants and Rara/g-
double nullmutants the anterior segment and eyelidsweremalformed
but not completely absent compared to Rara/b/gNCC−/− and Rarb/gNCC−/−
mutants. To resume,whereas the Rara/bNCC−/− eye phenotypewasmild,
consisting only in a persistent retrolenticular membrane, both Rara/
gNCC−/− and Rarb/gNCC−/− mutants presented a severe eye phenotype
(Table 1). Nonetheless, these phenotypes are milder compared to the
Rara/b/gNCC−/− eyes. Interestingly, the elongation of the optic nerve is
affected in Rara/gNCC−/− mutants but not in Rarb/gNCC−/− embryos
whereas the anterior segment was more affected in Rarb/gNCC−/−
embryos compared to Rara/gNCC−/−. Altogether, these data suggest that
the 3 RARs were implicated in the POMwith speciﬁc function for each
receptor.
Morphological defects in Rara/b/gNCC−/− eye primordia begin at E10.5
To identify the origin of the accumulated eye defects, we examined
Rara/b/gNCC−/− embryos after NCCs migration (i.e. E9.5). We used the
mouse line bearing a conditional reporter transgene (R26Rtg/0), which
expresses β-galactosidase only upon Cre-mediated recombination of a
loxP-ﬂanked (ﬂoxed) intervening DNA sequence (Soriano, 1999). This
line was crossed with the Rara/b/gNCC−/− mice and resulting embryos
(designated Rara/b/gNCC−/−lacZ) were taken at E9.5. First, we observed
the pattern of β-galactosidase activity identifying NCC derivatives and
concluded that theywere identical in eye area of E9.5 Rara/b/gNCC−/−lacZ
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of all 3 RARs in NCCs does not alter their migration into the periocular
region. These data allowed us to verify that the morphological defects
observed in Rara/b/gNCC−/− mutants did not result from alteration of
NCCs migration. Importantly, we observed that mutant and control
optic vesicles were histologically indistinguishable until E10.5 (Figs.
3A–D). Then, from this stage, Rara/b/gNCC−/− eye phenotype is char-
acterized by a systematic absence of the ventral eyelid groove. In
contrast, the optic stalk and optic cup were similar in both control and
mutant (arrowhead in Figs. 3E, F).
By E11.5, the eye defects of the Rara/b/gNCC−/− mutant became very
drastic and were recognizable externally (data not shown) as pig-
mented cells were not observed on the ventral side of the eye (Figs. 3G,
H). The initial speciﬁcation of the RPE appeared to occur normally inFig. 3. Defects in Rara/b/gNCC−/− eye primordial begin at E10.5. Frontal histological
sections through head of E9.5 (A, B), E10.0 (C, D), E10.5 (E, F), E11.5 (G, H) genotypes as
indicated. (A, B) distribution of β-galactosidase activity driven by the R26R transgene
in (A) WT and (B) Rara/b/gNCC−/− E9.5 embryos that are histologically similar. The
β-galactosidase staining is identical, indicating that ablation of all three RARs does not
alter the migration of NCCs in the POM. (C, D and G, H), Distribution of apoptotic cells
(assessed by TUNEL assays). Note the absence of the ventral eyelid groove (arrowhead in
panel F). Square brackets (C and D) indicate physiological apoptosis in optic stalk.
Asterisks (H) indicate undifferentiated mesenchyme replacing the eyelids and cornea. a,
apoptotic cluster in the POM. b, brain; d, dorsal retina; le, lens; m, muscle; n, optic
nerve; n⁎, undifferentiated optic nerve; os, optic stalk; ov, optic vesicle; pom, periocular
mesenchyme; r, neural retina; rpe, retinal pigmented epithelium; v, ventral retina.Rara/b/gNCC−/− embryo, since the mutant dorsal RPE was indistinguish-
able from the control at E10.5 (Figs. 3E, F). However, at E11.5, when the
RPE becomes pigmented, no pigment-containing cells were observed
in the remnant ventral RPE of the Rara/b/gNCC−/− mutant (data not
shown), suggesting that the expansion of the ventral RPE was blocked
in themutant eyes. As a consequence, an eversion of the ventral retina
is observed at E14.5 and E18.5 (Figs. 2H, K). In addition, the optic stalk
in Rara/b/gNCC−/− mouse remained a thick neuroblastic structure
whereas in control embryos, the optic stalk had begun to extend
and thin down, leading to the normal distance between the optic cup
and the ventral diencephalon (Figs. 3G, H). As a result, the mutant eye
remains closely associated with the ventral diencephalon by E14.5
(Fig. 2H).
It has been shown previously that RA triggers apoptosis in the
POM during eye formation. Indeed, the 2 physiological apoptotic
clusters observed in the POM during eye development are not found
in Rarb/gNCC−/− E11.5 mutants (Matt et al., 2005). To investigate the
RA-dependent physiological function of programmed cell death
during Rara/b/gNCC−/− eye formation, a TUNEL assay was performed
on serial histological sections along the anteroposterior axis of the eye
region at E10.0 and E11.5 (Figs. 3C, D and G, H). As expected, the
normal apoptotic clusters were consistently not detected in the POM
of Rara/b/gNCC−/− E11.5 embryos (Figs. 3G, H and data not shown).
Interestingly, as illustrated in Figs. 3 (G and H) and previously shown
by others (Cuadros and Rios, 1988; Ulshafer and Clavert, 1979), optic
nerve formation is also associated with a marked apoptotic cell death.
However, this wave of dying cells in the forming optic nerve was
similarly observed in the E10.0 and E11.5 mutant and control em-
bryos (Figs. 3C, D and G, H). Therefore, our data show that the ab-
normal development of optic nerve observed in Rara/b/gNCC−/− mutant
mice is not correlated with an abnormal regulation of apoptosis.
Although the undifferentiated mesenchyme in the POM area of the
E14.5 Rara/b/gNCC−/− mutants suggested that the anterior segment was
hypercellular, we were unable to ﬁnd evidence of increased prolifera-
tion in the POM of Rara/b/gNCC−/− mutant mice at E10.5 and E11.5 (data
not shown).
Pitx2 is not expressed in periocular mesenchyme of Rara/b/gNCC−/−
mutants
Amongst the genes involved in ocular development, the home-
odomain transcription factor PITX2 has been designated as a key
protein, playing essential functions during anterior segment pattern-
ing (Evans and Gage, 2005). At E11.5 this gene is expressed in the POM,
especially in the presumptive anterior segment. Interestingly, we have
previously reported that in E11.5, Rarb/gNCC−/− embryos, Pitx2 expres-
sion is reduced in the POM dorsal region (Matt et al., 2005).
Subsequent to this work, a mutant mouse in which Pitx2 expression
is speciﬁcally inactivated in NCCs (Pitx2NCC−/−) has been described
(Evans and Gage, 2005). This mutant is characterized by an abnormal
anterior segment differentiation, an absence of eyelids and exhibited a
failure to maintain the optic nerve. Interestingly, the same defects
are observed in Rara/b/gNCC−/− mutant. We therefore tested the ex-
pression of Pitx2 in Rara/b/gNCC−/− mutant. Importantly, we observed
that Pitx2 expression was totally absent in the periocular area of the
Rara/b/gNCC−/− E11.5 embryos (n=3, Figs. 4A, B) whereas its expression
in the pharyngeal ectoderm was not altered, demonstrating that the
expression of Pitx2 in the POM required RA signalling. Therefore, the
speciﬁc absence of Pitx2 expression in Rara/b/gNCC−/− demonstrates
that Pitx2 is a target of RA signalling in the POM.
Among the other genes involved in ocular development and
potential target of RA, Gas1 (Growth arrest speciﬁc gene 1) is a
relevant candidate. Indeed, Gas1-null mouse present microphthalmia,
anterior segment defects and eversion of the ventral retina (Lee et al.,
2001). Furthermore, microarray experiments using F9 embryonic
carcinoma cells exposed to RA suggest that Gas1 would be a RA-
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expression is detected at E11.5 in the dorsal and ventral tip of the
retina and in the mesenchyme surrounding the eye (i.e POM). How-
ever, this expression of Gas1 in the POM is similar in control mouse as
in Rara/b/gNCC−/− mutant (Figs. 4C, D). These data indicate that Gas1 is
not a target of RA signalling in the POM, and also that the absence of
RA signalling in the NCCs does not globally disrupt gene expression in
POM cells, but selectively decreases Pitx2.
Initial patterning of retina and optic nerve is not affected in
Rara/b/gNCC−/− mutants
To this date, only a few mutant mouse strains display a failure of
morphogenetic extension of the optic nerve. This severe defect inFig. 4. Ablation of Rara, Rarb and Rarg in neural crest cells impairs gene expression in
the POM but not in the retina. (A–J). In situ hybridization with digoxigenin-labeled
Pitx2, Gas1, Vax2 and Pax2 on frontal sections. Note the persistent expression of Pitx2 in
the pharyngeal ectoderm of the Rara/b/gNCC−/− mutants. b, brain; d, dorsal retina; g5,
trigeminal ganglion; le, lens; m, muscle; n, optic nerve; n⁎, undifferentiated optic nerve;
o, oral cavity; p, pituitary; pe, pharyngeal ectoderm; pom, periocular mesenchyme; rpe,
retinal pigmented epithelium; v, ventral retina.optic nerve development was described in Pitx2NCC−/− (Evans and
Gage, 2005). Importantly, it has been shown that the absence of the
optic nerve in this mutant was not due to a lack of initial speciﬁcation,
since the expression of an early marker of the optic stalk like Pax2 is
normal (Torres et al., 1996). On the basis of a similar severe optic nerve
phenotype in the Rara/b/gNCC−/− mutant and a down-regulation of
Pitx2 in this mutant, we have tested Pax2 expression at E11.0. Similarly
to Pitx2NCC−/− mutant, we observed that Pax2 was normally expressed
in the optic stalk of both control and Rara/b/gNCC−/− mutant (Figs. 4G,
H), establishing that a lack of initial speciﬁcation cannot account for
the optic stalk defects. In addition, and considering the absence of
ventral retina in E11.5 Rara/b/gNCC−/− mutant, we have evaluated the
dorsoventral polarity of the Rara/b/gNCC−/− mutant retina by studying
the expression of Tbx5 and Vax2 (McLaughlin et al., 2003). We did not
ﬁnd any difference in the expression patterns of Vax2 and Tbx5
between Rara/b/gNCC−/− mutant and control eye at E10.5 (Figs. 4I, J and
data not shown). Since the polarity of the neural retina is presumed to
be determined at E9.5, it indicates that initial patterning of the retina
was not signiﬁcantly affected.
Extraocular muscles are ectopic in Rara/b/gNCC−/− mutants
The extraocular muscles, which containmainlymesoderm-derived
myocytes but also neural crest-derived fascia cells, are normally
present as mesenchymal condensations lateral to the optic cup and
are characterized by the expression of Pitx2 at E11.5 (Fig. 4A). During
our histological analysis of Rara/b/gNCC−/− mutant, we observed that
extraocular muscle was not present in the periocular area (Figs. 2E,
H–K). We thus extended our analysis to the whole head using serial
sections. From this work, we detected a muscle-like tissue between
the trigeminal ganglion and the pituitary (Fig. 4F). In addition, this
muscle-like tissue exhibited speciﬁc mesodermal expression of Pitx2
(Fig. 4F) (Kitamura et al., 1999). These ectopic muscle-like structures
were still present at E14.5 between the trigeminal ganglion and the
pituitary (data not shown). Altogether, these observations demon-
strated that muscles were properly formed in mutant mice but
localized more caudally compared to its normal position lateral to the
optic cup. This result strengthens a recent report suggesting that early
craniofacial myogenesis is NCC-independent whereas migration of
head muscle cells would be regulated by cranial NCCs (Rinon et al.,
2007). Interestingly, this new model of total RA-deﬁciency in NCCs
has highlighted an unexpected role for RA signalling in ocular muscle
positioning. We therefore propose that RA in the NCCs provide
guidance cues to allowmuscle precursor cells tomigrate to the correct
position in the embryonic head.
Discussion
Sophisticated experimental genetics in mice provides a powerful
approach to understand developmental process by allowing precise
molecular, cellular and temporal dissection of gene function. Tissue-
speciﬁc knockouts are particularly useful when trying to understand
the function of a gene that is expressed in multiple cell lineages of a
developing organ. The triple Rara/b/gNCC−/− mutants generated here
give a new model to study RA function during eye development and
the data presented in this manuscript provide essential new
information toward the understanding of mammalian eye patterning.
In particular, our data demonstrate deﬁnitely the essential role of RA
in the POM to pattern the optic vesicle.
Eye development results from complex cell interactions between
neurectoderm (which give rise to the retina and optic nerve), the
surface ectoderm (which give rise to the lens, epithelia of the cornea,
conjunctiva and eyelids) and NCC-derived mesenchyme (which forms
the choroids, sclera, stroma of the cornea and iris, anterior chamber
and vitreous body) (Le Douarin et al., 1993). Previous studies using
either vitamin A deﬁciency, models, Rdh10, Aldh1a or Rar mutants
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these ocular structures (Dickman et al., 1997; Halilagic et al., 2007;
Lohnes et al., 1994; Mark et al., 2006; Matt et al., 2005; Sandell et al.,
2007). Consequently, it was thought that RA was required for various
morphogenetic processes in various eye tissues and at several stages
to pattern eye formation.
In contrast to this general assessment, we show that the complete
removal of RA activity only in the NCCs recapitulates all eye mal-
formations previously described in the various RA-deﬁcient models
(Halilagic et al., 2007; Lohnes et al., 1994; Mark et al., 2006). We have
thereby demonstrate for the ﬁrst time that the only target of RA
signalling is the NCC-derived mesenchyme and that impairing this
signal in this tissue is sufﬁcient to alter the entire eye morphogenesis.
RA is not required in the retina during its lamination
In the present study, we show that RA activity was absent from the
developing retina and RPE in Rara-null mutant between E10.5 and
E13.5. By this experiment, we demonstrated that Rara is the only RAR
capable to efﬁciently mediate RA activity in the developing retina and
RPE.
Previously it was hypothesized that RA maybe involved autono-
mously in dorsoventral patterning of the retina based upon the dorsal
and the ventral expression patterns of Aldh1a1 and Aldh1a3 respectively
in the retina from E10.5. However, studies on Aldh1a1−/−Aldh1a3−/−
embryos have shown that a lack of RA signalling in the retina from
E10.5 does not affect expression of dorso-ventral key determinants
like Tbx5 and Vax2 (Matt et al., 2005; Molotkov et al., 2006).
Additionally, the absence of RA-signalling in Rara-null retina did not
alter the expression of Vax2 and Tbx5. This indicates that RA does not
have an autonomous function in the dorso-ventral patterning of the
retina. Furthermore, the fact that Tbx5 and Vax2 are normally ex-
pressed in the Rara/b/gNCC−/− retina indicates that initial dorsoventral
patterning is also not affected and that RA does not regulate these
genes by a cell non-autonomous process.
Moreover, a later autonomous function for RA in the retina or RPE
should have been revealed by the Rara-null mutant. However, no
detectable eye defects were observed in adult Rara-null mutant eye.
Thus, our genetic studies demonstrate conclusively that RA signalling
has no autonomous function during retinal lamination. Thus RA is
dispensable within the retina for the formation of the eye. However,
an autonomous role for RA in more elaborate specialization of the
retina is still conceivable as our histological study cannot rule out
eventual more subtle defects in adult retina.
RARα, RARβ and RARγ are differently required in the periocular
mesenchymal NCCs
Since RARβ and RARγ are essential in the POM (Matt et al., 2005), it
had been postulated that these 2 receptors were the main receptors
involved in RA signalling in this tissue. In this study, we found major
ocular defects in Rara/gNCC−/− and Rarb/gNCC−/− but not in Rara/bNCC−/−.
Simultaneously, using the same approach, we also demonstrated that
RARγ was crucial for normal differentiation of the craniofacial NCCs
(V.D, unpublished). Altogether, it suggests that RARγ is the most im-
portant RAR implicated in cranial NCCs differentiation. Besides
highlighting the role of RARγ in NCCs differentiation, our data gives
a better understanding of the role of RARα during eye development.
Although comparison between phenotypes of RAR double null mu-
tants has suggested a role for RARα in eye development (Lohnes et al.,
1994), no studies were available to attribute a speciﬁc function to this
receptor. Here, we observed a strong genetic interaction in the POM
between Rara, Rarb and Rarg, demonstrating clearly a function of
RARα in this tissue. Precisely, complete absence of the optic nerve has
never been observed in the various combinations of Rar-double null
mutants.Furthermore, our data demonstrate that the role of each RAR is not
equivalent during ocular morphogenesis and that they are specialized
in patterning different NCCs-dependent structures. Rarb/gNCC−/−
mutants have the anterior segment and eyelids preferentially affected
whereas the optic nerve is normal and the ventral retina is present
while slightly shorter. In contrast, the couple of RARα and RARγ is
more important for optic disc invagination and nerve optic differ-
entiation since their inactivation in the POM produces an hypoplasic
optic nerve whereas the anterior segment and eyelid formation is less
severely affected compared to those of Rarb/gNCC−/− mutants. Thus,
RARβ is speciﬁcally involved cell-autonomously within the anterior
segment whereas RARα is rather implicated cell-non autonomously
during optic disc invagination and optic nerve maintenance.
During eye formation, RA signalling emerges in speciﬁc regions
while the eye undergoes a dramatic remodelling. In this sophisticated
process, the speciﬁc function of each ALDH1A and RAR were not clear
until now. Here, we clarify the sequential contribution of each actor of
the RA signalling to eye morphogenesis. By inactivating all 3 RARs in
the POM, we largely recapitulated the spectrum of eye phenotype of
Aldh1a2−/−Aldh1a3−/− mutant that have been RA supplemented
between E7.5 and E8.5 to rescue heart failure (Halilagic et al., 2007).
This Aldh1a2−/−Aldh1a3−/−mutant supplemented before E8.5 shows no
more RA-signal in the ocular region at E9.5 (Halilagic et al., 2007;
Molotkov et al., 2006) suggesting that ALDH1A2 and ALDH1A3 are the
main RA-producing enzyme in the POM at this stage. These data, as
well as the results described herein, demonstrate that the absence of
RA signalling in the ocular region from E9.5 is implicated in the
apparition of the Rara/b/gNCC−/− eye phenotypes. Thus, at this stage, RA
produced by ALDH1A2 and ALDH1A3 in the POM stimulates the
invagination of the optic vesicle and the formation of the optic nerve
(Molotkov et al., 2006). Here, we have shown that this event is mainly
mediated by RARα and RARγ in the POM and is therefore cell-non
autonomous. Subsequently, no additional RA-signal is found in the
ocular region of the Aldh1a1−/−Aldh1a3−/− mutant from E10.5 (Matt
et al., 2005; Molotkov et al., 2006). Thus, RA production is exclusively
performed by ALDH1A1 and ALDH1A3 from this stage. As the
phenotype of Aldh1a1−/−Aldh1a3−/− mutant is similar to Rarb/gNCC−/−
phenotype (Matt et al., 2005), this RAmainly activates RARβ and RARγ
to pattern the anterior segment, eyelids and late invagination of the
retina. A schematic presentation of these overall data is given in Fig. 5.
RA in the POM is crucial for optic nerve maintenance
The ocular defects observed in Rara/b/gNCC−/− mutants such as
abnormalities of the cornea, eyelids, anterior chamber, and presence
of PHPV, all correlate with the abnormal differentiation of cranial
NCCs (Cvekl and Tamm, 2004). This part of the phenotype has been
described in Rarb/gNCC−/− mutants and was found to be associated to a
decrease of Pitx2, Foxc1 and Eya2 expression in POM cells (Matt et al.,
2005). Here, by additionally removing RARα in the NCCs, we have
found that Pitx2 expression is fully abolished in the POM. Interest-
ingly, recent data have demonstrated that speciﬁc inactivation of Pitx2
in the NCCs induces an anterior segment dysgenesis but also defects in
the maintenance of the optic nerve, which closely resemble the ocular
defects displayed by Rara/b/gNCC−/− mutant mice (Evans and Gage,
2005).
As RA and PITX2 are both required in the periocular NCCs and as
PITX2 is absent in the POM of Rara/b/gNCC−/− mutant mouse, RA and
Pitx2 are involved in a simple linear genetic pathway. In this genetic
cascade, we propose that RARs are upstream of this pathway and
control the expression of Pitx2, which in turn is required for anterior
segment differentiation and optic nerve maintenance. While the
involvement of Pitx2 in RA signalling is clear from our experiments, a
direct action of RA on Pitx2 promoter remains unclear. We therefore
performed an in silico analysis of the Pitx2 gene and found no RARE
sequence in its promoter. In addition, the analysis of microarray
Fig. 5. ALDH1A1, ALDH1A2, ALDH1A3, RARα, RARβ and RARγ participate sequentially to eye morphogenesis. At E9.5, RARα and RARγ are activated by RA produces by ALDH1A2 and
ALDH1A3 to determine non-autonomously the RA-dependent optic nerve morphogenesis and invagination of the retina. Subsequently, from E10.5, RARβ and RARγ are activated by
RA produces by ALDH1A1 and ALDH1A3 to determine non-autonomously the late retinal invagination process and to control autonomously anterior segment morphogenesis. Light
blue indicates that the contribution of this speciﬁc RAR to the formation of the corresponding eye structure is weaker. Thick arrow represents the progressive RA-dependent stage of
the various eye structures.
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Therefore RA would regulate Pitx2 indirectly through a transcription
intermediary (Balmer and Blomhoff, 2002; Eifert et al., 2006).
In various models of RA-deﬁciency, including the Rara/b/gNCC−/−
mutant, anterior segment defect was associated with reduced apop-
tosis (present data; (Matt et al., 2005). Since, the same anterior
segment defects are observed in Rara/b/gNCC−/− and Pitx2NCC−/− mu-
tants, it can be suggested that Pitx2 triggers cell apoptosis in a linear
genetic pathway regulated by RA. However, since cell death was not
studied in the Pitx2NCC−/− mutant, we cannot conclude ﬁrmly that this
linear genetic pathway leads to cell apoptosis. In this process, Eya2
(Clark et al., 2002) could also be involved since its decreased ex-
pression in the POM was described for Rarb/gNCC−/− mutants (Matt
et al., 2005).
Other genes could also be included in this cascade. The transcrip-
tion factors Lmx1b and Foxc1 are notably required for normal anterior
segment development. These genes are co-expressed within the POM
and their inactivation results in anterior segment defects, although
less severe compared to those of Pitx2NCC−/− and Rara/b/gNCC−/−mutants
(Kidson et al., 1999; Pressman et al., 2000). Furthermore, the regu-
lation of Foxc1 by RA (Matt et al., 2005) strengthens the hypothesis
that these genes are involved in the RA-dependent molecular mecha-
nism leading to anterior segment morphogenesis.
The striking new phenotype of the Rara/b/gNCC−/−, as compared to
the other RARs loss-of-function models, is the absence of optic nerves.
These new data demonstrate that the POM is instrumental for optic
nerve maintenance in a RA-dependent process. Most interestingly,
Rara/b/gNCC−/− as Pitx2NCC−/− mutants displayed the same absence of
optic nerve (present data and Evans and Gage, 2005). Indeed, both
mutants exhibit normal initial speciﬁcation of the optic stalk as
testiﬁed by the expression of Pax2, followed by a failure to maintain
the optic nerve. Since these conditional mutants (Rara/b/gNCC−/− and
Pitx2NCC−/−) are speciﬁcally inactivated in the NCCs, the defect of the
optic stalk observed is the result of an impairment of an extrinsic
signal arising from the POM. We thus propose that RA in the POM
controls Pitx2 expression which, in turn, activates a yet unknown
paracrine factor that subsequently conditions the morphogenetic
extension of the optic stalk. We also point out that a cell-autonomous
(formation of the anterior segment) and non-autonomous (optic cup
morphogenesis) mechanisms, both RA-dependent, involve the same
target gene, i.e. Pitx2.
Altogether, our work clearly demonstrates that RA is not cell-
autonomously required in the neurectoderm to pattern eye morpho-
genesis. In contrast, ocular development required RA producing ecto-dermal cells, sending this RA signal to the POM, which in turn acts
on retina. It thus questions the presence of sophisticated Aldh1as
expression in the retina during eye development as previously
described (Wagner et al., 2000). It could be speculated that such
timely and regionally regulated RALDH expression could be an evolu-
tionary relic of an important mechanism present in lower vertebrates.
Another hypothesis is that such ALDH1As expression is indispensable
for retinal differentiation in order to acquire an elaborate retina with
high-acuity.
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